story of the week
CRP Flare Predicts Response to Anti–PD-L1 Immune Checkpoint Blockade in Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma
Eur. J. Cancer 2022 Mar 30;167(xx)13-22, N Klümper, D Sikic, J Saal, T Büttner, F Goldschmidt, J Jarczyk, P Becker, P Zeuschner, M Weinke, C Kalogirou, J Breyer, M Burger, P Nuhn, K Tully, F Roghmann, C Bolenz, F Zengerling, RM Wirtz, M Muders, G Kristiansen, T Bald, J Ellinger, B Wullich, M Hölzel, A Hartmann, P Erben, M Ritter, M EcksteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.